MASSIVE PROPRANOLOL METABOLITE RETENTION DURING MAINTENANCE HEMODIALYSIS

被引：27

作者：

STONE, WJ

WALLE, T

机构：

[1] VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37240

[2] MED UNIV S CAROLINA,DEPT PHARMACOL,CHARLESTON,SC 29401

来源：

关键词：

D O I：

10.1038/clpt.1980.187

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：449 / 455

页数：7

共 19 条

[1] BIANCHETTI G, 1976, Clinical Pharmacokinetics, V1, P373, DOI 10.2165/00003088-197601050-00004
[2] BRIGGS WA, 1975, CLIN PHARMACOL THER, V18, P606
[3] QUANTITATIVE-ANALYSIS OF NAPHTHOXYLACTIC ACID, A MAJOR METABOLITE OF PROPRANOLOL IN PLASMA IN MAN
EASTERLING, DE
WALLE, T
CONRADI, EC
GAFFNEY, TE
[J]. JOURNAL OF CHROMATOGRAPHY, 1979, 162 (03): : 439 - 445
[4] PHARMACOLOGY OF 4-HYDROXYPROPRANOLOL, A METABOLITE OF PROPRANOLOL
FITZ GERALD, JD
ODONNELL, SR
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1971, 43 (01) : 222 - +
[5] BETA-BLOCKADE WITH PINDOLOL - DIFFERENTIAL CARDIAC AND RENAL EFFECTS DESPITE SIMILAR PLASMA KINETICS IN NORMAL AND UREMIC MAN
GALEAZZI, RL
GUGGER, M
WEIDMANN, P
[J]. KIDNEY INTERNATIONAL, 1979, 15 (06) : 661 - 668
[6] LOWENTHAL D T, 1977, American Journal of Medicine, V62, P532, DOI 10.1016/0002-9343(77)90411-9
[7] CHRONIC HEMODYNAMIC EFFECTS OF PROPRANOLOL TREATMENT IN DIALYSIS-REFRACTORY HYPERTENSION
MAGGIORE, Q
ZOCCALI, C
MONZANI, G
CONTINI, C
[J]. NEPHRON, 1978, 22 (4-6): : 391 - 398
[8] SCHNECK DW, 1979, CLIN RES, V27, pA602
[9] SHAND DG, 1970, CLIN PHARMACOL THER, V11, P112
[10] STONE WJ, 1979, CLIN CHEM, V25, P1761